NASA’s Cognitive Tech Advances with TES-11 Launchby Lilu Anderson 14.08.2024Cognitive technology tested in space on TES-11 to automate satellite communications without human interaction.
Lilly Boosts R&D with $700M Boston Centerby Lilu Anderson 13.08.2024Lilly's new Boston facility enhances RNA/DNA research, hosting 500 scientists and expanding Gateway Labs to the East Coast.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Top Biotech Stocks to Watch: Expert Analysisby Lilu Anderson 13.08.2024Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
Tallinna Sadam’s Robust Financial Performance in Q2 2024by Mark Eisenberg 12.08.2024Tallinna Sadam reports a significant increase in revenue and profit for Q2 2024, highlighting strategic investments and operational efficiency.
Generative AI: Inductive vs. Deductive Reasoningby Lilu Anderson 12.08.2024Exploring the reasoning capabilities of AI: inductive and deductive challenges in generative models and their future implications.
EIC’s Strong Q2 2024 Boosted by Aerospace Growthby Mark Eisenberg 11.08.2024Exchange Income Corporation reports robust Q2 2024 results, driven by aerospace and aviation. Strategic growth bolstered by key acquisitions.
Bruker Reports 17.4% Revenue Growth in Q2 2024by Mark Eisenberg 10.08.2024Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
Top Movers: Sweetgreen, Intel, Akamai Surgeby Mark Eisenberg 10.08.2024Sweetgreen soars on strong earnings, while Intel drops. Akamai leads the S&P 500 on robust demand.
French Economy Sees 0.35% Q3 Growth from Olympic Boostby Mark Eisenberg 10.08.2024France's economy is projected to grow 0.35% in Q3, aided by Olympic-related activities, says the central bank.